{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:26:23Z","timestamp":1793298383086,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ahj.2013.01.025","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T01:03:12Z","timestamp":1365555792000},"page":"1008-1014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy"],"prefix":"10.1016","volume":"165","clinical-trial-number":[{"clinical-trial-number":"nct00239681","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jacqueline S.","family":"Danik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I.","family":"Chasman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean G.","family":"MacFadyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Nyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan J.","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Ridker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2013.01.025_bb0005","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2014a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.01.025_bb0010","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.jacc.2009.04.053","article-title":"The SLCO1B1*5 genetic variant is associated with statin-induced side effects","volume":"54","author":"Voora","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.01.025_bb0015","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/01.fpc.0000230416.82349.90","article-title":"SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid","volume":"16","author":"Pasanen","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.ahj.2013.01.025_bb0020","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/sj.clpt.6100220","article-title":"Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin","volume":"82","author":"Pasanen","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2013.01.025_bb0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/01.fpc.0000114750.08559.32","article-title":"High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)","volume":"14","author":"Niemi","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ahj.2013.01.025_bb0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clpt.2005.06.013","article-title":"Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment","volume":"78","author":"Lee","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2013.01.025_bb0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.clpt.6100267","article-title":"Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans","volume":"83","author":"Choi","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2013.01.025_bb0040","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.01.025_bb0045","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","article-title":"A randomized trial of rosuvastatin in the prevention of venous thromboembolism","volume":"360","author":"Glynn","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.01.025_bb0050","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/01.CIR.0000100688.17280.E6","article-title":"Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial","volume":"108","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.01.025_bb0055","unstructured":"MedDRA Maintenance and Support Services Organization. Introductory Guide, MedDRA version 10.1: International Federation of Pharmaceutical Manufacturers and Associations; 2007 Sep."},{"key":"10.1016\/j.ahj.2013.01.025_bb0060","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/CIRCGENETICS.111.961144","article-title":"Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial","volume":"5","author":"Chasman","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.ahj.2013.01.025_bb0065","unstructured":"www.nbci.nlm.nih.gov\/snp. Accessed June 12, 2012."},{"key":"10.1016\/j.ahj.2013.01.025_bb0070","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ahj.2013.01.025_bb0075","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ng1847","article-title":"Principal components analysis corrects for stratification in genome-wide association studies","volume":"38","author":"Price","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.ahj.2013.01.025_bb0080","doi-asserted-by":"crossref","unstructured":"Brown C, Windass A, Bleasby K, et al. Rosuvastatin is a high affinity substrate of hepatic organic anion transporter OATP-C. Atheroscler Suppl 2001;2:90. Abstract P174.","DOI":"10.1016\/S1567-5688(01)80225-7"},{"key":"10.1016\/j.ahj.2013.01.025_bb0085","doi-asserted-by":"crossref","first-page":"P64","DOI":"10.1016\/j.clpt.2004.12.136","article-title":"Multiple OATP transporters mediate the cellular uptake of rosuvastatin","volume":"77","author":"Ho","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2013.01.025_bb0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/01.fpc.0000170913.73780.5f","article-title":"Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells","volume":"15","author":"Kameyama","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.ahj.2013.01.025_bb0095","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00210-006-0040-y","article-title":"Pharmacogenomics of human OATP transporters","volume":"372","author":"Konig","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ahj.2013.01.025_bb0100","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1016\/S0149-2918(03)80336-3","article-title":"Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers","volume":"25","author":"Martin","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.ahj.2013.01.025_bb0105","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0022-3565(24)29609-9","article-title":"Human liver\u2013specific organic anion transporter, LST-1, mediates uptake of pravastatin by human hepatocytes","volume":"297","author":"Nakai","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ahj.2013.01.025_bb0110","doi-asserted-by":"crossref","first-page":"35669","DOI":"10.1074\/jbc.M103792200","article-title":"Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans","volume":"276","author":"Tirona","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ahj.2013.01.025_bb0115","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00008571-200411000-00006","article-title":"Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C)","volume":"14","author":"Iwai","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.ahj.2013.01.025_bb0120","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1124\/jpet.302.2.804","article-title":"Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis","volume":"302","author":"Nozawa","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ahj.2013.01.025_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/tpj.2009.54","article-title":"The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy","volume":"10","author":"Romaine","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.ahj.2013.01.025_bb0130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2133\/dmpk.19.453","article-title":"A novel variant allele of OATP-C (SLCO1B1) found in a Japanese patient with pravastatin-induced myopathy","volume":"19","author":"Morimoto","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.ahj.2013.01.025_bb0135","article-title":"The effects of a SNP in SLCO1B1 on the pharmacodynamics of pravastatin","author":"Martin","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2013.01.025_bb0140","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s10038-006-0025-1","article-title":"Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy","volume":"51","author":"Takane","year":"2006","journal-title":"J Hum Genet"},{"key":"10.1016\/j.ahj.2013.01.025_bb0145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01213011-200505000-00005","article-title":"Acute effects of pravastatin on cholesterol synthesis are associated with SLCO1B1 (encoding OATP1B1) haplotype *17","volume":"15","author":"Niemi","year":"2005","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.ahj.2013.01.025_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00210-006-0053-6","article-title":"Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels","volume":"373","author":"Gerloff","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ahj.2013.01.025_bb0155","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.atherosclerosis.2011.09.028","article-title":"Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly","volume":"220","author":"Akao","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2013.01.025_bb0160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2133\/dmpk.19.375","article-title":"Effect of genetic polymorphism of OATP-C (SLCO1B1) on lipid-lowering response to HMG-CoA reductase inhibitors","volume":"19","author":"Tachibana-Iimori","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.ahj.2013.01.025_bb0165","doi-asserted-by":"crossref","first-page":"28B","DOI":"10.1016\/S0002-9149(01)01454-0","article-title":"Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"87","author":"McTaggart","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.01.025_bb0170","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00003088-200039060-00002","article-title":"Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events","volume":"39","author":"Hatanaka","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ahj.2013.01.025_bb0175","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/jps.2600800905","article-title":"Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin","volume":"80","author":"Serajuddin","year":"1991","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ahj.2013.01.025_bb0180","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.CIR.0000032466.44170.44","article-title":"ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins","volume":"106","author":"Pasternak","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.01.025_bb0185","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1345\/aph.1M410","article-title":"Does simvastatin cause more myotoxicity compared with other statins?","volume":"43","author":"Backes","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ahj.2013.01.025_bb0190","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.atherosclerosis.2010.02.026","article-title":"Genetic involvement in statins induced myopathy. Preliminary data from an observational case-control study","volume":"211","author":"Puccetti","year":"2010","journal-title":"Atherosclerosis"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:49:23Z","timestamp":1757569763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870313000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0002870313000859"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2013.01.025","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2013.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}